| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 371.323.972 $ | 99,93 | 2.216.644 | |||||||
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 54.367.122 $ | 14,63 | 390.092 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 54.037.827 $ | 14,54 | 153.582 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 29.941.847 $ | 8,06 | 67.053 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 27.917.028 $ | 7,51 | 36.132 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 19.608.673 $ | 5,28 | 26.852 | |
| Insmed Inc | Insmed Inc | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 17.053.501 $ | 4,59 | 104.290 | |
| IQVIA Holdings Inc | IQVIA Holdings Inc | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 15.971.242 $ | 4,30 | 93.651 | |
| Alnylam Pharmaceuticals Inc | Alnylam Pharmaceuticals Inc | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 15.259.724 $ | 4,11 | 46.120 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 14.785.461 $ | 3,98 | 73.931 | |
| United Therapeutics Corp | United Therapeutics Corp | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 14.146.131 $ | 3,81 | 23.856 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 13.830.965 $ | 3,72 | 75.443 | |
| BeOne Medicines Ltd | BeOne Medicines Ltd | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 12.063.515 $ | 3,25 | 40.622 | |
| Moderna Inc | Moderna Inc | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 11.527.028 $ | 3,10 | 226.910 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 10.635.746 $ | 2,86 | 109.365 | |
| Illumina Inc | Illumina Inc | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 9.260.894 $ | 2,49 | 75.133 | |
| Incyte Corp | Incyte Corp | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 8.354.656 $ | 2,25 | 88.766 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 8.006.044 $ | 2,15 | 90.077 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 7.196.693 $ | 1,94 | 54.628 | |
| BioMarin Pharmaceutical Inc | BioMarin Pharmaceutical Inc | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 5.174.315 $ | 1,39 | 91.597 | |
| Bio-Techne Corp | Bio-Techne Corp | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 5.006.665 $ | 1,35 | 95.803 | |
| Charles River Laboratories International Inc | Charles River Laboratories International Inc | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 4.750.478 $ | 1,28 | 27.539 | |
| ICON PLC | ICON PLC | EC | IE0005711209 | Long | Börsenkurs (Stufe 1) | 4.727.174 $ | 1,27 | 42.718 | |
| QIAGEN NV | QIAGEN NV | EC | NL0015002SN0 | Long | Börsenkurs (Stufe 1) | 4.256.612 $ | 1,15 | 106.309 | |
| Tempus AI Inc | Tempus AI Inc | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 3.444.634 $ | 0,93 | 76.175 | |
| 371.323.972 $ | 99,93 | 2.216.644 |